Yuhan Corporation acquires Progen, a multi-target antibody company based in South Korea for total of $23M investment
Yuhan Corporation announced on April 5, 2023, that it has signed an investment agreement to secure the largest shareholder stake in Progen Inc., a company with multi-target antibody-based platform technology. Progen Inc. is a biotechnology company with 25 years of experience in platform-based drug discovery and development. The company has a platform technology for immunoglobulin […]